Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.
Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.
复制标题
DOI:
10.1007/s00467-013-2430-y
复制
发表时间:
2014-03
影响因子:
3
通讯作者:
Yamaguchi, Ikuyo
中科院分区:
文献类型:
--
作者:
Kida, Yujiro;Tchao, Bie Nga;Yamaguchi, Ikuyo
Chronic kidney disease (CKD) is epidemic around the world and desparately needs new therapies. Peritubular capillary (PTC) rarefaction, along with interstitial fibrosis and tubular atorophy, is one of the major hallmarks of CKD and predicts renal outcome in patients with CKD. PTC endothelial cells (ECs) undergo apoptosis during CKD, leading to capillary loss, tissue hypoxia, and oxidant stress. Although the mechanisms of PTC rarefaction are not well understood, the process of PTC rarefaction depends on multiple events that happen during CKD. These events, which lead to an antiangiogenic environment, include deprivation of EC survival factors, increased production of vascular growth inhibitors, malfunction of ECs, dysfunction of endothelial progenitor cells, and loss of EC integrity via pericyte detachment from vasculature. In this review, we focus on major factors regulating angiogenesis and EC survival and describe roles of these factors in PTC rarefaction during CKD and possible therapeutic applications.
登录
查看更多内容
DOI:
10.1152/ajprenal.00293.2005
发表时间:
2007-01-01
影响因子:
4.2
作者:
Burt, Laura E.;Forbes, Michael S.;Chevalier, Robert L.
通讯作者:
Chevalier, Robert L.
影响因子:
158.5
作者:
Eremina, Vera;Jefferson, J. Ashley;Quaggin, Susan E.
通讯作者:
Quaggin, Susan E.
影响因子:
64.8
作者:
Carmeliet, Peter;Jain, Rakesh K.
通讯作者:
Jain, Rakesh K.
影响因子:
2.5
作者:
Bellini, Maria H.;Coutinho, Enia L.;Schor, Nestor
通讯作者:
Schor, Nestor
DOI:
10.1152/ajprenal.00294.2005
发表时间:
2007-01-01
影响因子:
4.2
作者:
Burt, Laura E.;Forbes, Michael S.;Chevalier, Robert L.
通讯作者:
Chevalier, Robert L.